Kelly Lamarco

Title: The Innovative Contributions of Kelly Lamarco

Introduction

Kelly Lamarco is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of biotechnology, particularly in the development of assays for identifying inhibitors of pathogenic nucleic acid polymerases. With a total of 3 patents, her work has the potential to impact the treatment of various viral infections.

Latest Patents

One of her latest patents is a high-throughput screening assay for inhibitors of nucleic acid. This invention provides both promoter-specific and promoter non-specific screening assays for identifying inhibitors of pathogenic nucleic acid polymerase activity. The methods involve forming a mixture of nucleotides, a polynucleotide template, and a candidate inhibitor, where at least one nucleotide comprises a detectable label. The mixture is incubated under specific conditions to allow the polymerase to transcribe the polynucleotide template, and the nascent transcript is captured for subsequent detection.

Another notable patent is related to a Herpes Simplex Virus drug screen. This invention involves Host Cell Factor (HCF), a eukaryotic cellular protein that plays a crucial role in transcription. The patent discloses HCF-specific binding compounds, including antibodies to HCF epitopes. The invention provides pharmaceutical compositions and methods for screening chemical libraries for regulators of viral transcription, which can be used in the treatment of viral infections.

Career Highlights

Throughout her career, Kelly has worked with notable organizations such as Tularik Limited and Cold Spring Harbor Laboratory. Her experience in these institutions has allowed her to develop innovative solutions in the field of molecular biology and virology.

Collaborations

Kelly has collaborated with esteemed colleagues, including Angus Wilson and Winship Herr. These partnerships have further enhanced her research and contributions to the scientific community.

Conclusion

Kelly Lamarco's innovative work in developing assays for pathogenic nucleic acid inhibitors and her contributions to viral transcription research highlight her significant impact in biotechnology. Her patents reflect her dedication to advancing medical science and improving treatment options for viral infections.